This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, X. Articles by Aliev, G. Search for Related Content PubMed PubMed Citation Articles by Zhu, X. Articles by Aliev, G. Social Bookmarking                   What's this?

Mitochondrial failures in Alzheimer's disease

Mark A. Smith, PhD

Institute of Pathology, Case Western Reserve University, Cleveland, Ohio.

George Perry, PhD

Gjumrakch Aliev, MD, PhD

Departments of Pathology and the Microscopy Research Center, Case Western Reserve University, Cleveland, Ohio.

Mitochondrial dysfunction and free radical-induced oxidative damage have been implicated in the pathogenesis of several different neurodegenerative diseases such as Parkinson disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and Alzheimer's disease (AD). The defective adenosine triphosphate (ATP) production and increased oxygen radicals may induce mitochondria-dependent cell death because damaged mitochondria are unable to maintain the energy demands of the cell. The role of vascular hypoperfusion-induced mitochondria failure in the pathogenesis of AD now has been widely accepted. However, the exact cellular mechanisms behind vascular lesions and their relation to oxidative stress markers identified by RNA oxidation, lipid peroxidation, or mitochondrial DNA (mt DNA) deletion remain unknown. Future studies comparing the spectrum of mitochondrial damage and the relationship to oxidative stress-induced damage during the aging process or, more importantly, during the maturation of AD pathology are warranted.

Key Words: mitochondria • Alzheimer's disease • hypoperfusion • mitochondrial DNA deletion • amyloid cascade

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Irwin, C. F. Lippa, and J.M. Swearer Cognition and Amyotrophic Lateral Sclerosis (ALS) American Journal of Alzheimer's Disease and Other Dementias, September 1, 2007; 22(4): 300 - 312. [Abstract] [PDF]

				M. S Parihar and G. J. Brewer Mitoenergetic failure in Alzheimer disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23. [Abstract] [Full Text] [PDF]

				D. Zhu, Y. Lai, P. B. Shelat, C. Hu, G. Y. Sun, and J. C-M. Lee Phospholipases A2 Mediate Amyloid-beta Peptide-Induced Mitochondrial Dysfunction J. Neurosci., October 25, 2006; 26(43): 11111 - 11119. [Abstract] [Full Text] [PDF]

				L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci., August 30, 2006; 26(35): 9057 - 9068. [Abstract] [Full Text] [PDF]

				S. E. Perez, O. Lazarov, J. B. Koprich, E.-Y. Chen, V. Rodriguez-Menendez, J. W. Lipton, S. S. Sisodia, and E. J. Mufson Nigrostriatal Dysfunction in Familial Alzheimer's Disease-Linked APPswe/PS1{Delta}E9 Transgenic Mice J. Neurosci., November 2, 2005; 25(44): 10220 - 10229. [Abstract] [Full Text] [PDF]